Quick Takeaways
- Reshma Rangwala has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $503,232.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Reshma Rangwala
- Location
- Newton, MA
- Summary
- The estimated net worth of Reshma Rangwala is at least $503,232 dollars as of 22 Apr 2026. Reshma Rangwala is the EVP & Chief Medical Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $503.2K.
- Signature
- /s/ Nancy Smith as Attorney-in-Fact for Reshma Rangwala
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Reshma Rangwala and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Karyopharm Therapeutics Inc. ($503,232).
- Past-year value change for that position: -$54,306.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Reshma Rangwala
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | EVP & Chief Medical Officer | $503,232 | -$54,306 | -9.7% | 21 Apr 2026 |
| ARAV | Aravive, Inc. | Chief Medical Officer | 24 Jan 2022 |
Insider Transactions Reported by Reshma Rangwala:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.